Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp

Journal of Clinical Microbiology
M A PfallerD J Diekema

Abstract

Cross-resistance within a class of antimicrobial agents is a problem that is often encountered with antibacterial agents, and it is also an issue with antifungal agents. A current example is ravuconazole, a new triazole antifungal with an expanded spectrum and potency against Candida spp., Aspergillus spp., and other opportunistic fungal pathogens. The present study addresses the issue of cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict the susceptibility of Candida spp. to ravuconazole. Reference broth microdilution MIC results for 12,796 strains of Candida spp. isolated from more than 200 medical centers worldwide were used. Ravuconazole MICs and tentative interpretive categories (susceptible, </=1 microg/ml; resistant, >/=2 microg/ml) were compared with those of fluconazole by using regression statistics and error rate bounding analyses. For all 12,796 isolates, the absolute categorical agreement rate was 92.5% (rate of false-susceptible results, or very major errors [VME], 0.1%). Ravuconazole was active (MIC, </=1 microg/ml) against 99.9% of the fluconazole-susceptible isolates, 96% of the fluconazole-susceptible dose-dependent isolates, and 49% of the flucona...Continue Reading

References

Sep 19, 2000·Antimicrobial Agents and Chemotherapy·T YamazumiR N Jones
Jun 19, 2001·Diagnostic Microbiology and Infectious Disease·R N JonesUNKNOWN SENTRY Antimicrobial Surveillance Program Participants Group (USA)
Oct 2, 2002·Journal of Clinical Microbiology·M A Pfaller, D J Diekema
Oct 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H Rex, Michael A Pfaller
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·D AndesR Conklin
Jan 30, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M A PfallerUNKNOWN International Fungal Surveillance Participant Group

❮ Previous
Next ❯

Citations

Jul 11, 2006·Folia Microbiologica·A Bialková, J Subík
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zeina A Kanafani, John R Perfect
Jan 22, 2005·Current Opinion in Pediatrics·Charalampos Antachopoulos, Thomas J Walsh
May 28, 2009·Antimicrobial Agents and Chemotherapy·Marçal MarinéJosep Guarro
Sep 3, 2010·Medical Mycology·Homan HanasabEva J Helmerhorst
Jun 1, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Claudio L DonniciMaria A de Resende Stoianoff
Jul 24, 2013·BioMed Research International·Claudia Spampinato, Darío Leonardi
Oct 7, 2009·Expert Review of Anti-infective Therapy·Maria Teresa FeraAngelina De Sarro
Jul 23, 2009·Expert Review of Anti-infective Therapy·Emilia CantónJavier Pemán
Mar 23, 2011·Expert Review of Anti-infective Therapy·Ozden Türel
Dec 2, 2008·Expert Opinion on Pharmacotherapy·Ioanna FiliotiEmmanuel Roilides
May 31, 2006·Expert Opinion on Investigational Drugs·George Aperis, Eleftherios Mylonakis
Aug 15, 2009·Expert Opinion on Investigational Drugs·Corrado Girmenia
Nov 6, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·M A PfallerUNKNOWN CLSI Subcommittee for Antifungal Susceptibility Testing
Nov 23, 2006·Transplant Infectious Disease : an Official Journal of the Transplantation Society·S S Magill, L K Dropulic
Dec 2, 2005·Clinical Techniques in Small Animal Practice·Richard F Hector
Jan 10, 2014·Journal of Clinical Microbiology·Annette W FothergillNathan P Wiederhold
Jun 12, 2010·Expert Opinion on Pharmacotherapy·Varsha Moudgal, Jack Sobel
Nov 13, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Marianne de Lucena RangelRicardo Dias de Castro
Mar 24, 2009·Mycoses·Tatiane Caroline DaboitMaria Lúcia Scroferneker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.